Neumann Capital Management LLC lessened its stake in CVS Health Corp (NYSE:CVS) by 6.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,536 shares of the pharmacy operator’s stock after selling 3,750 shares during the period. CVS Health accounts for about 2.4% of Neumann Capital Management LLC’s portfolio, making the stock its 11th largest position. Neumann Capital Management LLC’s holdings in CVS Health were worth $3,881,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of CVS. Hunter Associates Investment Management LLC grew its holdings in CVS Health by 2.6% during the 2nd quarter. Hunter Associates Investment Management LLC now owns 3,905 shares of the pharmacy operator’s stock worth $314,000 after acquiring an additional 100 shares in the last quarter. Glovista Investments LLC grew its holdings in CVS Health by 1.7% during the 2nd quarter. Glovista Investments LLC now owns 6,149 shares of the pharmacy operator’s stock worth $495,000 after acquiring an additional 100 shares in the last quarter. Columbia Asset Management grew its holdings in CVS Health by 1.2% during the 2nd quarter. Columbia Asset Management now owns 8,498 shares of the pharmacy operator’s stock worth $683,000 after acquiring an additional 101 shares in the last quarter. Bontempo Ohly Capital Mgmt LLC grew its holdings in CVS Health by 0.5% during the 2nd quarter. Bontempo Ohly Capital Mgmt LLC now owns 21,830 shares of the pharmacy operator’s stock worth $1,756,000 after acquiring an additional 109 shares in the last quarter. Finally, Ropes Wealth Advisors LLC grew its holdings in CVS Health by 2.5% during the 2nd quarter. Ropes Wealth Advisors LLC now owns 7,217 shares of the pharmacy operator’s stock worth $581,000 after acquiring an additional 173 shares in the last quarter. 83.96% of the stock is currently owned by institutional investors.

How to Become a New Pot Stock Millionaire

Several brokerages have issued reports on CVS. Morgan Stanley upgraded shares of CVS Health from an “equal weight” rating to an “overweight” rating and set a $88.00 target price on the stock in a report on Friday, January 5th. Needham & Company LLC increased their target price on shares of CVS Health from $85.00 to $88.00 and gave the stock a “buy” rating in a report on Tuesday, January 2nd. SunTrust Banks increased their target price on shares of CVS Health to $90.00 and gave the stock a “buy” rating in a report on Friday, January 5th. Leerink Swann set a $85.00 target price on shares of CVS Health and gave the stock a “buy” rating in a report on Friday, February 9th. Finally, Mizuho set a $95.00 target price on shares of CVS Health and gave the stock a “buy” rating in a report on Wednesday, January 24th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $87.03.

Shares of CVS Health Corp (CVS) opened at $61.79 on Friday. CVS Health Corp has a 1-year low of $61.74 and a 1-year high of $84.00. The firm has a market cap of $63,327.09, a PE ratio of 10.54, a PEG ratio of 1.03 and a beta of 1.03. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.88 by $0.04. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The business had revenue of $48.39 billion for the quarter, compared to analysts’ expectations of $47.54 billion. During the same period last year, the business earned $1.71 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. sell-side analysts predict that CVS Health Corp will post 6.37 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 3rd. Investors of record on Monday, April 23rd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.24%. The ex-dividend date of this dividend is Friday, April 20th. CVS Health’s payout ratio is currently 30.91%.

In related news, EVP Helena Foulkes sold 19,965 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $71.04, for a total value of $1,418,313.60. Following the completion of the transaction, the executive vice president now directly owns 65,072 shares of the company’s stock, valued at approximately $4,622,714.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.61% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CVS Health Corp (CVS) Position Reduced by Neumann Capital Management LLC” was first published by Daily Political and is the property of of Daily Political. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/03/23/cvs-health-corp-cvs-position-reduced-by-neumann-capital-management-llc.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.